Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Epidemiology of dementia: prevalence and incidence estimates using validated electronic health records from primary care.

Ponjoan A, Garre-Olmo J, Blanch J, Fages E, Alves-Cabratosa L, Martí-Lluch R, Comas-Cufí M, Parramon D, Garcia-Gil M, Ramos R.

Clin Epidemiol. 2019 Mar 4;11:217-228. doi: 10.2147/CLEP.S186590. eCollection 2019.

2.

Prognostic value of the estimated glomerular filtration rate decline in hypertensive patients without chronic kidney disease.

Coll-de-Tuero G, Comas-Cufí M, Rodríguez-Poncelas A, Barrot-de-la Puente J, Blanch J, Figa-Vaello J, Barceló MA, Saez M.

Am J Hypertens. 2019 Feb 22. pii: hpz029. doi: 10.1093/ajh/hpz029. [Epub ahead of print]

PMID:
30794282
3.

Hypertension and high ankle brachial index: the overlooked combination.

Alves-Cabratosa L, Elosua-Bayes M, García-Gil M, Comas-Cufí M, Martí-Lluch R, Ponjoan A, Blanch J, Parramon D, Gomez-Marcos MA, Ramos R.

J Hypertens. 2019 Jan;37(1):92-98. doi: 10.1097/HJH.0000000000001861.

PMID:
30507863
4.

Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.

Ramos R, Comas-Cufí M, Martí-Lluch R, Balló E, Ponjoan A, Alves-Cabratosa L, Blanch J, Marrugat J, Elosua R, Grau M, Elosua-Bayes M, García-Ortiz L, Garcia-Gil M.

BMJ. 2018 Sep 5;362:k3359. doi: 10.1136/bmj.k3359.

5.

Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study.

Rodriguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cufí M, Saez M, Barceló MA.

J Nephrol. 2018 Oct;31(5):743-749. doi: 10.1007/s40620-018-0524-0. Epub 2018 Aug 27.

PMID:
30151699
6.

Number of Patients Eligible for PCSK9 Inhibitors Based on Real-world Data From 2.5 Million Patients.

Zamora A, Masana L, Comas-Cufi M, Plana N, Vila À, García-Gil M, Alves-Cabratosa L, Elosua R, Marrugat J, Ramos R.

Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1010-1017. doi: 10.1016/j.rec.2018.03.003. Epub 2018 Mar 30. English, Spanish.

PMID:
29606363
7.

Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population-Based Cohort Study.

Garcia-Gil M, Comas-Cufí M, Blanch J, Martí R, Ponjoan A, Alves-Cabratosa L, Petersen I, Marrugat J, Elosua R, Grau M, Ramos R.

Clin Pharmacol Ther. 2018 Oct;104(4):719-732. doi: 10.1002/cpt.954. Epub 2018 Feb 2.

8.

Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General Mediterranean Population.

Elosua-Bayés M, Martí-Lluch R, García-Gil MDM, Camós L, Comas-Cufí M, Blanch J, Ponjoan A, Alves-Cabratosa L, Elosua R, Grau M, Marrugat J, Ramos R.

Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):458-465. doi: 10.1016/j.rec.2017.09.011. Epub 2017 Oct 25. English, Spanish.

PMID:
29079281
9.

Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015.

Alves-Cabratosa L, García-Gil M, Comas-Cufí M, Ponjoan A, Martí-Lluch R, Parramon D, Blanch J, Elosua-Bayes M, Ramos R.

PLoS One. 2017 Oct 26;12(10):e0186972. doi: 10.1371/journal.pone.0186972. eCollection 2017.

10.

Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.

Baena-Díez JM, Garcia-Gil M, Comas-Cufí M, Ramos R, Prieto-Alhambra D, Salvador-González B, Elosua R, Dégano IR, Peñafiel J, Grau M.

Heart. 2018 Jan;104(2):119-126. doi: 10.1136/heartjnl-2017-311279. Epub 2017 Aug 28.

PMID:
28847852
11.

Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients.

Zamora A, Masana L, Comas-Cufí M, Vila À, Plana N, García-Gil M, Alves-Cabratosa L, Marrugat J, Roman I, Ramos R; XULA and ISV-Girona groups.

J Clin Lipidol. 2017 Jul - Aug;11(4):1013-1022. doi: 10.1016/j.jacl.2017.05.012. Epub 2017 Jun 3.

12.

Differences in cardio-ankle vascular index in a general Mediterranean population depending on the presence or absence of metabolic cardiovascular risk factors.

Martí-Lluch R, Garcia-Gil MDM, Camós L, Comas-Cufí M, Elosua-Bayés M, Blanch J, Ponjoan A, Alves-Cabratosa L, Elosua R, Grau M, Marrugat J, Ramos R.

Atherosclerosis. 2017 Sep;264:29-35. doi: 10.1016/j.atherosclerosis.2017.07.013. Epub 2017 Jul 13.

PMID:
28756313
13.

Effects of extreme temperatures on cardiovascular emergency hospitalizations in a Mediterranean region: a self-controlled case series study.

Ponjoan A, Blanch J, Alves-Cabratosa L, Martí-Lluch R, Comas-Cufí M, Parramon D, Del Mar Garcia-Gil M, Ramos R, Petersen I.

Environ Health. 2017 Apr 4;16(1):32. doi: 10.1186/s12940-017-0238-0.

14.

Reply: Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.

Ramos R, Comas-Cufí M, Alves-Cabratosa L, García-Gil M.

J Am Coll Cardiol. 2016 Jul 12;68(2):238. doi: 10.1016/j.jacc.2016.04.029. No abstract available.

15.

Role of renal function in cardiovascular risk assessment: A retrospective cohort study in a population with low incidence of coronary heart disease.

García-Gil M, Parramon D, Comas-Cufí M, Martí R, Ponjoan A, Alves-Cabratosa L, Blanch J, Petersen I, Elosua R, Grau M, Salvador B, Ramos R.

Prev Med. 2016 Aug;89:200-206. doi: 10.1016/j.ypmed.2016.06.004. Epub 2016 Jun 7.

16.

Diabetes and new-onset atrial fibrillation in a hypertensive population.

Alves-Cabratosa L, García-Gil M, Comas-Cufí M, Martí R, Ponjoan A, Parramon D, Blanch J, Ramos R.

Ann Med. 2016;48(3):119-27. doi: 10.3109/07853890.2016.1144930. Epub 2016 Mar 3.

PMID:
26939743
17.

Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical records.

García-Gil M, Blanch J, Comas-Cufí M, Daunis-i-Estadella J, Bolíbar B, Martí R, Ponjoan A, Alves-Cabratosa L, Ramos R.

J Clin Lipidol. 2016 Jan-Feb;10(1):134-42. doi: 10.1016/j.jacl.2015.10.007. Epub 2015 Oct 21.

18.

Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.

Ramos R, García-Gil M, Comas-Cufí M, Quesada M, Marrugat J, Elosua R, Sala J, Grau M, Martí R, Ponjoan A, Alves-Cabratosa L, Blanch J, Bolíbar B.

J Am Coll Cardiol. 2016 Feb 16;67(6):630-640. doi: 10.1016/j.jacc.2015.11.052.

19.

Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders.

Agüero F, González-Zobl G, Baena-Díez JM, Dégano IR, Garcia-Gil M, Alzamora MT, Marrugat J, Comas-Cufí M, Pera G, Elosua R, Ramos R, Grau M.

Atherosclerosis. 2015 Sep;242(1):1-7. doi: 10.1016/j.atherosclerosis.2015.06.054. Epub 2015 Jun 30.

20.

Incident atrial fibrillation hazard in hypertensive population: a risk function from and for clinical practice.

Alves-Cabratosa L, García-Gil M, Comas-Cufí M, Ponjoan A, Martí R, Parramon D, Blanch J, Ramos R.

Hypertension. 2015 Jun;65(6):1180-6. doi: 10.1161/HYPERTENSIONAHA.115.05198. Epub 2015 Apr 6. Retraction in: Hypertension. 2016 Jun;67(6):e23.

PMID:
25847950

Supplemental Content

Loading ...
Support Center